The AI Scientist is designed to be compute efficient. Each idea is implemented and developed into a full paper at a cost of approximately $15 per paper. While there are still occasional flaws in the papers produced by this first version (discussed below and in the report), this cost and the promise the system shows so far illustrate the potential of The AI Scientist to democratize research and significantly accelerate scientific progress.

We believe this work signifies the beginning of a new era in scientific discovery: bringing the transformative benefits of AI agents to the entire research process, including that of AI itself. The AI Scientist takes us closer to a world where endless affordable creativity and innovation can be unleashed on the world’s most challenging problems.

For decades following each major AI advance, it has been common for AI researchers to joke amongst themselves that “now all we need to do is figure out how to make the AI write the papers for us!” Our work demonstrates this idea has gone from a fantastical joke so unrealistic everyone thought it was funny to something that is currently possible.

Scientists are experimenting with enzymes that turn sugar to fiber in the gut, microscopic sponges to soak up sugar, and more.

We’ve detected that JavaScript is disabled in this browser. Please enable JavaScript or switch to a supported browser to continue using x.com. You can see a list of supported browsers in our Help Center.

Help Center

Terms of Service Privacy Policy Cookie Policy Imprint Ads info © 2024 X Corp.

In a new study, a molecule identified and synthesized by UCLA Health researchers was shown to restore cognitive functions in mice with symptoms of Alzheimer’s disease by effectively jumpstarting the brain’s memory circuitry.

If proven to have similar effects in humans, the candidate compound would be novel among Alzheimer’s disease treatments in its ability to revitalize memory and cognition, study authors said.

There is really nothing like this on the market or experimentally that has been shown to do this.

Aging is the major risk factor for the development of chronic diseases such as cardiovascular disease, cancer, diabetes, and dementia. Therefore, drugs that slow the aging process may help extend both lifespan and healthspan (the length of time that people are healthy).

In a study published online on February 29 in Medical Research Archives, Albert Einstein College of Medicine researchers evaluated U.S. Food and Drug Administration-approved drugs for their anti-aging potential. In ranking those drugs, they gave equal weight to preclinical studies (i.e., effect on rodent lifespan and healthspan) and clinical studies (i.e., reduced mortality from diseases the drugs were not intended to treat). The four therapeutics judged most promising for targeting aging were SGLT2 inhibitors, metformin, bisphosphonates, and GLP-1 receptor agonists. Since these drugs have been approved for safety and used extensively, the researchers recommend they be evaluated for their anti-aging potential in large-scale clinical trials.

The study’s corresponding author was Nir Barzilai, M.D., director of Einstein’s Institute for Aging Research, professor of medicine and of genetics and the Ingeborg and Ira Leon Rennert Chair in Aging Research at Einstein, and a member of the National Cancer Institute–designated Montefiore Einstein Comprehensive Cancer Center. The lead author was Michael Leone, a medical student at Einstein.

Stretchy seaweed. reverse vending machines. qr-coded take-out boxes. to cure our addiction to disposable crap, we’ll all need to get a little loony.

Researchers wish to probe whether consciousness has a basis in quantum mechanical phenomena.

By Hartmut Neven & Christof Koch

Oxford scientists make new solar cell technology discovery which you could soon wear, stick on your mobile or coat your car with.

SOM, the architecture firm behind some of the world’s tallest buildings, is working to develop gravity energy storage solutions for skyscrapers and other buildings.

Helen Edwards was a particle physicist who led the design and construction of the Tevatron, a machine built to probe deeper into the atom than anyone had gone before.